• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物反应不佳的癌痛。第1部分:临床考量。

Opioid poorly-responsive cancer pain. Part 1: clinical considerations.

作者信息

Mercadante S, Portenoy R K

机构信息

Anesthesia and Intensive Care Unit & Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy.

出版信息

J Pain Symptom Manage. 2001 Feb;21(2):144-50. doi: 10.1016/s0885-3924(00)00228-1.

DOI:10.1016/s0885-3924(00)00228-1
PMID:11226765
Abstract

Pain that is poorly responsive to opioid analgesics is challenging for physicians who deal with cancer patients. Numerous factors may influence analgesic response during the course of the illness. These include changing nociception associated with disease progression, the appearance of intractable side effects, the development of tolerance, the presence of neuropathic pain, the temporal pattern, the effects produced by the production of opioid metabolites, and many others. These factors influence the delicate balance between pain relief and opioid toxicity that must be achieved in cancer patients with pain.

摘要

对阿片类镇痛药反应不佳的疼痛,给治疗癌症患者的医生带来了挑战。在疾病过程中,众多因素可能会影响镇痛效果。这些因素包括与疾病进展相关的伤害感受变化、顽固性副作用的出现、耐受性的形成、神经性疼痛的存在、时间模式、阿片类代谢产物产生的影响等等。这些因素影响着癌症疼痛患者必须实现的疼痛缓解与阿片类药物毒性之间的微妙平衡。

相似文献

1
Opioid poorly-responsive cancer pain. Part 1: clinical considerations.阿片类药物反应不佳的癌痛。第1部分:临床考量。
J Pain Symptom Manage. 2001 Feb;21(2):144-50. doi: 10.1016/s0885-3924(00)00228-1.
2
Predictive factors and opioid responsiveness in cancer pain.
Eur J Cancer. 1998 Apr;34(5):627-31. doi: 10.1016/s0959-8049(97)10053-3.
3
Opioid and adjuvant analgesics: compared and contrasted.阿片类和辅助镇痛药:比较与对比
Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26.
4
Opioid analgesics in cancer pain: current practice and controversies.癌症疼痛中的阿片类镇痛药:当前的实践与争议
Cancer Surv. 1988;7(1):29-53.
5
Monitoring of opioid therapy in advanced cancer pain patients.晚期癌症疼痛患者阿片类药物治疗的监测
J Pain Symptom Manage. 1997 Apr;13(4):204-12. doi: 10.1016/s0885-3924(96)00302-8.
6
The pharmacologic management of cancer pain.癌症疼痛的药物治疗
Oncology (Williston Park). 2004 Oct;18(12):1499-515; discussion 1516, 1520-1, 1522, 1524.
7
Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit.胃肠外途径给予氯胺酮作为重度疼痛的镇痛辅助药物:姑息治疗病房一项方案的制定与回顾性审计
J Palliat Med. 2005 Feb;8(1):49-57. doi: 10.1089/jpm.2005.8.49.
8
Opioid-responsive and opioid-non-responsive pain in cancer.癌症中对阿片类药物有反应和无反应的疼痛
Br Med Bull. 1991 Jul;47(3):718-31. doi: 10.1093/oxfordjournals.bmb.a072503.
9
Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin.长期使用阿片类镇痛药治疗非恶性来源的慢性疼痛。
J Pain Symptom Manage. 1993 Jul;8(5):279-88. doi: 10.1016/0885-3924(93)90156-p.
10
Misperceptions and inadequate pain management in cancer patients.癌症患者的错误认知与疼痛管理不足
DICP. 1991 Nov;25(11):1225-30. doi: 10.1177/106002809102501112.

引用本文的文献

1
Ghrelin Induces the Production of Hypothalamic NPY Through the AMPK-mTOR Pathway to Alleviate Cancer-induced Bone Pain.胃饥饿素通过 AMPK-mTOR 通路诱导下丘脑 NPY 的产生,以缓解癌性骨痛。
In Vivo. 2024 May-Jun;38(3):1133-1142. doi: 10.21873/invivo.13548.
2
Upregulation of μ-Opioid Receptor in the Rat Spinal Cord Contributes to the α2-Adrenoceptor Agonist Dexmedetomidine-Induced Attenuation of Chronic Morphine Tolerance in Cancer Pain.大鼠脊髓中μ阿片受体的上调有助于α2肾上腺素能受体激动剂右美托咪定减轻癌症疼痛中慢性吗啡耐受性。
J Pain Res. 2020 Oct 15;13:2617-2627. doi: 10.2147/JPR.S274225. eCollection 2020.
3
Spinal cord stimulation alleviates intractable pain due to malignant pleural mesothelioma: a case report.
脊髓刺激缓解恶性胸膜间皮瘤所致顽固性疼痛:一例报告
JA Clin Rep. 2020 Oct 6;6(1):78. doi: 10.1186/s40981-020-00386-9.
4
Hydroethanolic Stem Bark Extract of Attenuates Vincristine-Induced Peripheral Neuropathy in Rats.[植物名称]的水乙醇茎皮提取物减轻长春新碱诱导的大鼠周围神经病变。 (你提供的原文中植物名称缺失,我按格式要求进行了翻译,但请补充完整植物名称以便更准确表意。)
Adv Pharmacol Pharm Sci. 2020 Feb 12;2020:7232579. doi: 10.1155/2020/7232579. eCollection 2020.
5
The Complex Balance between Analgesic Efficacy, Change of Dose and Safety Profile Over Time, in Cancer Patients Treated with Opioids: Providing the Clinicians with an Evaluation Tool.阿片类药物治疗的癌症患者中,镇痛效果、剂量变化及安全性随时间的复杂平衡:为临床医生提供一种评估工具
J Clin Med. 2020 Feb 12;9(2):502. doi: 10.3390/jcm9020502.
6
Lack of Efficacy: When Opioids Do Not Achieve Analgesia from the Beginning of Treatment in Cancer Patients.疗效欠佳:癌症患者从治疗开始使用阿片类药物时未实现镇痛效果的情况。
Cancer Manag Res. 2019 Dec 10;11:10337-10344. doi: 10.2147/CMAR.S211818. eCollection 2019.
7
The Patient with Difficult Cancer Pain.患有难治性癌痛的患者。
Cancers (Basel). 2019 Apr 19;11(4):565. doi: 10.3390/cancers11040565.
8
Topical morphine for treatment of cancer-related painful mucosal and cutaneous lesions: a double-blind, placebo-controlled cross-over clinical trial.局部用吗啡治疗癌症相关疼痛性黏膜和皮肤病变:一项双盲、安慰剂对照交叉临床试验。
Arch Med Sci. 2019 Jan;15(1):146-151. doi: 10.5114/aoms.2018.72566. Epub 2018 Jan 2.
9
Effects of Electroacupuncture Treatment on Bone Cancer Pain Model with Morphine Tolerance.电针治疗对吗啡耐受骨癌痛模型的影响。
Evid Based Complement Alternat Med. 2016;2016:8028474. doi: 10.1155/2016/8028474. Epub 2016 Sep 8.
10
MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1.微小RNA参与吗啡诱导的镇痛耐受性的发展并调节Serpini1中功能相关的变化。
Front Mol Neurosci. 2016 Mar 24;9:20. doi: 10.3389/fnmol.2016.00020. eCollection 2016.